INTRODUCTION: The goal of this project was to create an up-to-date joint European clinical practice guideline for the diagnosis and treatment of faecal incontinence (FI), using the best available evidence. These guidelines are intended to help guide all medical professionals treating adult patients with FI (e.g., general practitioners, surgeons, gastroenterologists, other healthcare workers) and any patients who are interested in information regarding the diagnosis and management of FI. METHODS: These guidelines have been created in cooperation with members from the United European Gastroenterology (UEG), European Society of Coloproctology (ESCP), European Society of Neurogastroenterology and Motility (ESNM) and the European Society for Primary Care Gastroenterology (ESPCG). These members made up the guideline development group (GDG). Additionally, a patient advisory board (PAB) was created to reflect and comment on the draft guidelines from a patient perspective. Relevant review questions were established by the GDG along with a set of outcomes most important for decision making. A systematic literature search was performed using these review questions and outcomes as a framework. For each predefined review question, the study or studies with the highest level of study design were included. If evidence of a higher-level study design was available, no lower level of evidence was sought or included. Data from the studies were extracted by two reviewers for each predefined important outcome within each review question. Where possible, forest plots were created. After summarising the results for each review question, a systematic quality assessment using the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) approach was performed. For each review question, we assessed the quality of evidence for every predetermined important outcome. After evidence review and quality assessment were completed, recommendations could be formulated. The wording used for each recommendation was dependent on the level of quality of evidence. Lower levels of evidence resulted in weaker recommendations and higher levels of evidence resulted in stronger recommendations. Recommendations were discussed within the GDG to reach consensus. RESULTS: These guidelines contain 45 recommendations on the classification, diagnosis and management of FI in adult patients. CONCLUSION: These multidisciplinary European guidelines provide an up-to-date comprehensive evidence-based framework with recommendations on the diagnosis and management of adult patients who suffer from FI.

Center for Functional GI and Motility Disorders University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Charles University Hospital Hradec Kralove Czech Republic

Community Gastroenterology Specialist Nurse Royal Free Hospital London England UK

Department of Gastroenterology and Hepatology University Hospital Zurich Zurich Switzerland

Department of Gastrointestinal Surgery University Hospital of North Norway Tromsø Norway

Department of General Practice Care and Public Health Research Institute Maastricht University Maastricht The Netherlands

Department of Surgery and Colorectal Surgery Maastricht University Medical Centre Maastricht The Netherlands

Department of Surgery and Colorectal Surgery Western General Hospital Edinburgh UK

Division of Gastroenterology Hepatology Department of Internal Medicine Maastricht University Medical Centre Maastricht The Netherlands

Division of Gastroenterology of the University of Verona AOUI Verona Verona Italy

Maastricht University Maastricht The Netherlands

Mater Misericordiae University Hospital Dublin 7 Ireland

Medical Academy Lithuanian University of Health Sciences Clinic of Surgery Hospital of Lithuanian University of Health Sciences Kauno Klinikos Kaunas Lithuania

Norwegian National Advisory Unit on Incontinence and Pelvic Floor Health Tromsø Norway

Patient Advisory Board Representative Maastricht The Netherlands

rth TOMY Academic Primary Care Unit Clinic of Social and Family Medicine University of Crete Heraklion Greece

School for Oncology and Developmental Biology Maastricht University Maastricht The Netherlands

School of Nutrition and Translational Research in Metabolism Maastricht University Maastricht The Netherlands

St Mark's Hospital The National Bowel Hospital London UK

Surgical Professorial Unit Department of Colorectal Surgery St Vincent's University Hospital Dublin Ireland

The University of Adelaide Adelaide Medical School Faculty of Health and Medical Sciences Adelaide Australia

Tor Vergata University of Rome Rome Italy

Erratum v

United European Gastroenterol J. 2022 Jul;10(6):606-607. doi: 10.1002/ueg2.12258. PubMed

Komentář v

United European Gastroenterol J. 2022 Jul;10(6):601-602. doi: 10.1002/ueg2.12263. PubMed

Komentář v

United European Gastroenterol J. 2022 Jul;10(6):603-604. doi: 10.1002/ueg2.12261. PubMed

Zobrazit více v PubMed

GRADE WG. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. PubMed PMC

Carrington E, Scott S, Bharucha A, Bharucha A, Mion F, Remes‐Troche JM, et al. International Anorectal Physiology Working Group and the International Working Group for Disorders of Gastrointestinal Motility and Function . Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol. 2018;15:309–23. PubMed PMC

National Institute for Health and Clinical Excellence . Faecal incontinence: the management of faecal incontinence in adults NICE; 2007.

Rao SS, Bharucha AE, Chiarioni G, Felt‐Bersma R, Knowles C, Malcolm A, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430–42. PubMed PMC

Pahwa AK, Khanijow KD, Harvie HS, Arya LA, Andy UU. Comparison of patient impact and clinical characteristics between urgency and passive fecal incontinence phenotypes. Female Pelvic Med Reconstr Surg. 2020;26(9):570–4. PubMed PMC

Norton C, Kamm M. Outcome of biofeedback for faecal incontinence. Br J Surg. 1999;86(9):1159–63. PubMed

Hotouras A, Thaha MA, Boyle DJ, Allison ME, Currie A, Knowles CH, et al. Short‐term outcome following percutaneous tibial nerve stimulation for faecal incontinence: a single‐centre prospective study. Colorectal Dis. 2012;14(9):1101–5. PubMed

Brown HW, Guan W, Schmuhl NB, Smith PD, Whitehead WE, Rogers RG. If we don't ask, they won't tell: screening for urinary and fecal incontinence by primary care providers. J Am Board Fam Med. 2018;31(5):774–82. PubMed PMC

Keighley MR, Williams NS. Keighley & Williams' surgery of the anus, rectum and colon: two‐volume set CRC Press; 2018.

Cichowski SB, Dunivan GC, Rogers RG, Komesu YM. Patients' experience compared with physicians' recommendations for treating fecal incontinence: a qualitative approach. Int Urogynecol J. 2014;25(7):935–40. PubMed PMC

Jelovsek JE, Markland AD, Whitehead WE, Barber MD, Newman DK, Rogers RG, et al. Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial. Lancet Gastroenterol Hepatol. 2019;4(9):698–710. PubMed PMC

Norton C, Chelvanayagam S, Wilson‐Barnett J, Redfern S, Kamm MA. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology. 2003;125(5):1320–9. PubMed

Colavita K, Andy UU. Role of diet in fecal incontinence: a systematic review of the literature. Int Urogynecol J. 2016;27(12):1805–10. PubMed

Menees SB, Chandhrasekhar D, Liew EL, Chey WD. A low FODMAP diet may reduce symptoms in patients with fecal incontinence. Clin Transl Gastroenterol. 2019;10(7):e00060. PubMed PMC

Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, et al. Interventions for preventing and treating incontinence‐associated dermatitis in adults. Cochrane Database Syst Rev. 2016;11. PubMed PMC

Pather P, Hines S, Kynoch K, Coyer F. Effectiveness of topical skin products in the treatment and prevention of incontinence‐associated dermatitis: a systematic review. JBI Database Syst Rev Implement Rep. 2017;15(5):1473–96. PubMed

Cooper P, Gray D. Comparison of two skin care regimes for incontinence. Br J Nurs. 2001;10(6 Suppl):S6, S8, S10 passim. PubMed

Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K. A 3‐in‐1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence‐associated dermatitis: a randomized, controlled clinical trial. J Wound Ostomy Continence Nurs. 2011;38(6):627–34. PubMed

Anthony D, Barnes E, Malone‐Lee J, Pluck R. A clinical study of Sudocrem in the management of dermatitis due to the physical stress of incontinence in a geriatric population. J Adv Nurs. 1987;12(5):599–603. PubMed

Brunner M, Droegemueller C, Rivers S, Deuser WE. Prevention of incontinence‐related skin breakdown for acute and critical care patients: comparison of two products. Urol Nurs. 2012;32(4):214‐9. PubMed

Lewis‐Byers K, Thayer D. An evaluation of two incontinence skin care protocols in a long‐term care setting. Ostomy Wound Manage. 2002;48(12):44. PubMed

Buckley B, Dofitas R, Baltazar W, Quiambao P, Razor B. Topical zinc oxide based creams in a structured care regimen for the treatment of incontinence associated dermatitis in hospitalized adults and older children: a randomized, controlled trial. Neurourol Urodyn. 2014;33(6):760–1.

Fader M, Cottenden A, Getliffe K, Gage H, Clarke‐O'Neill S, Jamieson K, et al. Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs. Health Technol Assess. 2008;12(29). iii‐iv, ix‐185. PubMed

Norton C, Cody JD. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev. 2012;7:CD002111. PubMed PMC

Vonthein R, Heimerl T, Schwandner T, Ziegler A. Electrical stimulation and biofeedback for the treatment of fecal incontinence: a systematic review. Int J Colorectal Dis. 2013;28(11):1567–77. PubMed PMC

Enck P, Van der Voort IR, Klosterhalfen S. Biofeedback therapy in fecal incontinence and constipation. Neuro Gastroenterol Motil. 2009;21(11):1133–41. PubMed

Heymen S, Jones KR, Ringel Y, Scarlett Y, Whitehead WE. Biofeedback treatment of fecal incontinence: a critical review. Dis Colon Rectum. 2001;44(5):728–36. PubMed

Palsson OS, Heymen S, Whitehead WE. Biofeedback treatment for functional anorectal disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2004;29(3):153–74. PubMed

Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum. 2009;52(10):1730–7. PubMed PMC

Ilnyckyj A, Fachnie E, Tougas G. A randomized‐controlled trial comparing an educational intervention alone vs education and biofeedback in the management of faecal incontinence in women. Neuro Gastroenterol Motil. 2005;17(1):58–63. PubMed

Bliss DZ, Jung HJ, Savik K, Lowry A, LeMoine M, Jensen L, et al. Supplementation with dietary fiber improves fecal incontinence. Nurs Res. 2001;50(4):203–13. PubMed

Bliss DZ, Savik K, Jung HJ, Whitebird R, Lowry A, Sheng X. Dietary fiber supplementation for fecal incontinence: a randomized clinical trial. Res Nurs Health. 2014;37(5):367–78. PubMed PMC

Markland AD, Burgio KL, Whitehead WE, Richter HE, Wilcox CM, Redden DT, et al. Loperamide versus psyllium fiber for treatment of fecal incontinence: the fecal incontinence prescription (Rx) management (FIRM) randomized clinical trial. Dis Colon Rectum. 2015;58(10):983–93. PubMed

Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013;6:CD002116. PubMed PMC

Edenfield AL, Amundsen CL, Wu JM, Levin PJ, Siddiqui NY. Posterior tibial nerve stimulation for the treatment of fecal incontinence: a systematic evidence review. Obstet Gynecol Surv. 2015;70(5):329–41. PubMed

Arroyo‐Fernández R, Avendaño‐Coy J, Ando‐Lafuente S, Martín‐Correa T, Ferri‐Morales A. Posterior tibial nerve stimulation in the treatment of fecal incontinence: a systematic review. Rev Esp Enferm Dig. 2018;110(9):577–88. PubMed

Sarveazad A, Babahajian A, Amini N, Shamseddin J, Yousefifard M. Posterior tibial nerve stimulation in fecal incontinence: a systematic review and meta‐analysis. Basic Clin Neurosci. 2019;10(5):419–32. PubMed PMC

Horrocks E, Thin N, Thaha M, Taylor S, Norton C, Knowles C. Systematic review of tibial nerve stimulation to treat faecal incontinence. Br J Surg. 2014;101(5):457–68. PubMed

Findlay JM, Maxwell‐Armstrong C. Posterior tibial nerve stimulation and faecal incontinence: a review. Int J Colorectal Dis. 2011;26(3):265–73. PubMed

Tan K, Wells CI, Dinning P, Bissett IP, O'Grady G. Placebo response rates in electrical nerve stimulation trials for fecal incontinence and constipation: a systematic review and meta‐analysis. Neuromodulation. 2020. Dec 1;23(8):1108–16. PubMed

George A, Kalmar K, Sala S, Kopanakis K, Panarese A, Dudding T, et al. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg. 2013;100(3):330–8. PubMed

Leroi A, Siproudhis L, Etienney I, Damon H, Zerbib F, Amarenco G, et al. Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a). Am J Gastroenterol. 2012;107(12):1888–96. PubMed

Knowles CH, Horrocks EJ, Bremner SA, Stevens N, Norton C, O'Connell PR, et al. Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double‐blind, multicentre, pragmatic, parallel‐group, randomised controlled trial. Lancet (London, England). 2015;386(10004):1640–8. PubMed

van der Wilt AA, Giuliani G, Kubis C, van Wunnik BPW, Ferreira I, Breukink SO, et al. Randomized clinical trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in patients with faecal incontinence. Br J Surg. 2017;104(9):1167–76. PubMed

Simillis C, Lal N, Qiu S, Kontovounisios C, Rasheed S, Tan E, et al. Sacral nerve stimulation versus percutaneous tibial nerve stimulation for faecal incontinence: a systematic review and meta‐analysis. Int J Colorectal Dis. 2018;33(5):645–8. PubMed

Thaha MA, Abukar AA, Thin NN, Ramsanahie A, Knowles CH. Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database Syst Rev. 2015;8. PubMed PMC

Hotouras A, Murphy J, Allison M, Curry A, Williams NS, Knowles CH, et al. Prospective clinical audit of two neuromodulatory treatments for fecal incontinence: sacral nerve stimulation (SNS) and percutaneous tibial nerve stimulation (PTNS). Surg Today. 2014;44(11):2124–30. PubMed

Juul T, Christensen P. Prospective evaluation of transanal irrigation for fecal incontinence and constipation. Tech Coloproctol. 2017;21(5):363–71. PubMed

Buono K, Davé‐Heliker B. Mechanical inserts for the treatment of faecal incontinence: a systematic review. Arab J Urol. 2019;17(1):69–76. PubMed PMC

Deutekom M, Dobben AC. Plugs for containing faecal incontinence. Cochrane Database Syst Rev. 2015(7). PubMed PMC

How P, Trivedi P, Bearn P, Thomas G. Insert devices for faecal incontinence. Tech Coloproctol. 2020:1–11. PubMed

Mortensen N, Humphreys MS. The anal continence plug: a disposable device for patients with anorectal incontinence. Lancet. 1991;338(8762):295–7. PubMed

Christiansen J, Roed‐Petersen K. Clinical assessment of the anal continence plug. Dis Colon Rectum. 1993;36(8):740–2. PubMed

Norton C, Kamm M. Anal plug for faecal incontinence. Colorectal Dis. 2001;3(5):323–7. PubMed

Lukacz ES, Segall MM, Wexner SD. Evaluation of an anal insert device for the conservative management of fecal incontinence. Dis Colon Rectum. 2015;58(9):892–8. PubMed

Leo CA, Thomas GP, Hodgkinson JD, Segal JP, Maeda Y, Murphy J, et al. The Renew R anal insert for passive faecal incontinence: a retrospective audit of our use of a novel device. Colorectal Dis. 2019;21(6):684–8. PubMed

Giamundo P, Altomare D, De Nardi P, D’Onofrio V, Infantino A, Pucciani F, et al. The ProTect device in the treatment of severe fecal incontinence: preliminary results of a multicenter trial. Tech Coloproctol. 2007;11(4):310–14. PubMed

Giamundo P, Welber A, Weiss EG, Vernava AM III, Nogueras JJ, Wexner SD. The procon incontinence device: a new nonsurgical approach to preventing episodes of fecal incontinence. Am J Gastroenterol. 2002;97(9):2328–32. PubMed

Jarrett MED, Mowatt G, Glazener CMA, Fraser C, Nicholls RJ, Grant AM, et al. Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg. 2004;91(12):1559–69. PubMed

Tan E, Ngo N‐T, Darzi A, Shenouda M, Tekkis PP. Meta‐analysis: sacral nerve stimulation versus conservative therapy in the treatment of faecal incontinence. Int J Colorectal Dis. 2011;26(3):275–94. PubMed

Ratto C, Litta F, Parello A, Donisi L, De Simone V, Zaccone G. Sacral nerve stimulation in faecal incontinence associated with an anal sphincter lesion: a systematic review. Colorectal Dis. 2012;14(6):e297–304. PubMed

Mirbagheri N, Sivakumaran Y, Nassar N, Gladman MA. Systematic review of the impact of sacral neuromodulation on clinical symptoms and gastrointestinal physiology. ANZ J Surg. 2016;86(4):232–6. PubMed PMC

Zhu Y, Wu G, Zhang J, Yan W, Han M, Zhang H, et al. [Meta‐analysis of sacral nerve stimulation for fecal incontinence]. Zhonghua Wei Chang Wai Ke Za Zhi [Chinese Journal of Gastrointestinal Surgery]. 2017;20(12):1417–21. PubMed

Kahlke V, Topic H, Peleikis HG, Jongen J. Sacral nerve modulation for fecal incontinence: results of a prospective single‐center randomized crossover study. Dis Colon Rectum. 2015;58(2):235–40. PubMed

Leroi A‐M, Parc Y, Lehur P‐A, Mion F, Barth X, Rullier E, et al. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double‐blind crossover study. Ann Surg. 2005;242(5):662–9. PubMed PMC

Sorensen M, Thomsen F. Sacral nerve stimulation increases rectal sensitivity in patients with faecal incontinence: results of a randomised double‐blinded crossover study (Abstract number 437). In: Proceedings of the joint meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010, Aug 23‐27, Toronto, Canada [Internet]; 2010. Available from: https://www.cochranelibrary.com/central/doi/10.1002/central/CN‐00766350/full DOI

Vaizey CJ, Kamm MA, Roy AJ, Nicholls RJ. Double‐blind crossover study of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum. 2000;43(3):298–302. PubMed

Tjandra JJ, Chan MKY, Yeh CH, Murray‐Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum. 2008;51(5):494–502. PubMed

Maeda Y, Matzel K, Lundby L, Buntzen S, Laurberg S. Postoperative issues of sacral nerve stimulation for fecal incontinence and constipation: a systematic literature review and treatment guideline. Dis Colon Rectum. 2011;54(11):1443–60. PubMed

Leroi A‐M, Lenne X, Dervaux B, Chartier‐Kastler E, Mauroy B, Normand LL, et al. Outcome and cost analysis of sacral nerve modulation for treating urinary and/or fecal incontinence. Ann Surg. 2011;253(4):720–32. PubMed

Brosa M, Munoz‐Duyos A, Navarro‐Luna A, Rodriguez JM, Serrano D, Gisbert R, et al. Cost‐effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain. Curr Med Res Opin. 2008;24(3):907–18. PubMed

Indinnimeo M, Ratto C, Moschella CM, Fiore A, Brosa M, Giardina S. Sacral neuromodulation for the treatment of fecal incontinence: analysis of cost‐effectiveness. Dis Colon Rectum. 2010;53(12):1661–9. PubMed

Rydningen M, Dehli T, Wilsgaard T, Rydning A, Kumle M, Lindsetmo RO, et al. Sacral neuromodulation compared with injection of bulking agents for faecal incontinence following obstetric anal sphincter injury – a randomized controlled trial. Colorectal Dis. 2017;19(5):O134–44. PubMed

Bernstein MA, Purdy CH, Becker A, Magar R. Three‐year cost‐effectiveness model for non‐animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence. Clin Therapeut. 2014;36(6):890–905. PubMed

Ratto C, Litta F, Parello A, Donisi L, Doglietto GB. Sacral nerve stimulation is a valid approach in fecal incontinence due to sphincter lesions when compared to sphincter repair. Dis Colon Rectum. 2010;53(3):264–72. PubMed

Hong KD, Kim J, Ji WB, Um JW. Midterm outcomes of injectable bulking agents for fecal incontinence: a systematic review and meta‐analysis. Tech Coloproctol. 2017;21(3):203–10. PubMed

Winkler R, Wild C. [Injectable bulking agents for faecal incontinence: systematic review]. Health Technol Assess Decis Supp Doc. 2015;87:1–41.

Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013(2):CD007959. PubMed PMC

Leung FW. Treatment of fecal incontinence (FI) by injection of bulking agent into peri‐anal tissue‐review of observational studies (OS) and randomized controlled trials (RCT). Neuro Gastroenterol Motil. 2011;1:21. PubMed PMC

Luo C, Samaranayake CB, Plank LD, Bissett IP. Systematic review on the efficacy and safety of injectable bulking agents for passive faecal incontinence. Colorectal Dis. 2010;12(4):296–303. PubMed

Siproudhis L, Morcet J, Laine F. Elastomer implants in faecal incontinence: a blind, randomized placebo‐controlled study. Aliment Pharmacol Ther. 2007;25(9):1125–32. PubMed

Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M, et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham‐controlled trial. Lancet. 2011;377(9770):997–1003. PubMed

Dehli T, Stordahl A, Vatten LJ, Romundstad PR, Mevik K, Sahlin Y, et al. Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol. 2013;48(3):302–10. PubMed

Forte ML, Andrade KE, Lowry AC, Butler M, Bliss DZ, Kane RL. Systematic review of surgical treatments for fecal incontinence. Dis Colon Rectum. 2016;59(5):443–69. PubMed

Malouf AJ, Norton CS, Engel AF, Nicholls RJ, Kamm MA. Long‐term results of overlapping anterior anal‐sphincter repair for obstetric trauma. Lancet. 2000;355(9200):260–5. PubMed

Colquhoun P, Kaiser R Jr., Efron J, Weiss EG, Nogueras JJ, Vernava AM 3rd, et al. Is the quality of life better in patients with colostomy than patients with fecal incontience? World J Surg. 2006;30(10):1925–8. PubMed

Kon Y, Ichikawa‐Shigeta Y, Iuchi T, Nakajima Y, Nakagami G, Tabata K, et al. Effects of a skin barrier cream on management of incontinence‐associated dermatitis in older women: a cluster randomized controlled trial. J Wound Ostomy Continence Nurs. 2017;44(5):481–6. PubMed

Chassagne P, Jego A, Gloc P, Capet C, Trivalle C, Doucet J, et al. Does treatment of constipation improve faecal incontinence in institutionalized elderly patients? Age Ageing. 2000;29(2):159–64. PubMed

Schnelle JF, Leung FW, Rao SSC, Beuscher L, Keeler E, Clift JW, et al. A controlled trial of an intervention to improve urinary and fecal incontinence and constipation. J Am Geriatr Soc. 2010;58((8):1504–11. PubMed PMC

Christensen P, Bazzocchi G, Coggrave M, Abel R, Hultling C, Krogh K, et al. A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord‐injured patients. Gastroenterology. 2006;131(3):738–47. PubMed

Barak N, Gecse KB, Takacs I. Topical oxymetazoline for fecal incontinence in patients with spinal cord injury: a double‐blind randomized controlled crossover study. Dis Colon Rectum. 2019;62(2):234–40. PubMed

Coggrave M, Norton C, Cody JD. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev. 2014(1):CD002115. PubMed PMC

Kong E, Nikolaou S, Qiu S, Pellino G, Tekkis P, Kontovounisios C. A systematic review of sacral nerve stimulation for faecal incontinence following ileal pouch anal anastomosis. Updates Surg. 2018;70(1):1–5. PubMed PMC

Lumi CM, La Rosa L, Coraglio MF, Munoz JP, Gualdrini UA, Masciangioli G. [Prospective, double‐blind study of topical phenylephrine treatment for nocturnal fecal incontinence in patients after ileoanal pouch construction]. Acta Gastroenterol Latinoam. 2009;39(3):179–83. PubMed

Mege D, Meurette G, Vitton V, Leroi AM, Bridoux V, Zerbib P, et al. Sacral nerve stimulation can alleviate symptoms of bowel dysfunction after colorectal resections. Colorectal Dis. 2017;19(8):756–63. PubMed

Ramage L, Qiu S, Kontovounisios C, Tekkis P, Rasheed S, Tan E. A systematic review of sacral nerve stimulation for low anterior resection syndrome. Colorectal Dis. 2015;17(9):762–71. PubMed

Ram E, Meyer R, Carter D, Gutman M, Rosin D, Horesh N. The efficacy of sacral neuromodulation in the treatment of low anterior resection syndrome: a systematic review and meta‐analysis. Tech Coloproctol. 2020;24(8):803–15. PubMed

Lin K‐Y, Granger CL, Denehy L, Frawley HC. Pelvic floor muscle training for bowel dysfunction following colorectal cancer surgery: a systematic review. Neurourol Urodyn. 2015;34(8):703–12. PubMed

Lin YH, Yang HY, Hung SL, Chen HP, Liu KW, Chen TB, et al. Effects of pelvic floor muscle exercise on faecal incontinence in rectal cancer patients after stoma closure. Eur J Cancer Care. 2016;25(3):449–57. PubMed

Park J‐S, Kang S‐B, Kim D‐W, Namgung H‐W, Kim H‐L. The efficacy and adverse effects of topical phenylephrine for anal incontinence after low anterior resection in patients with rectal cancer. Int J Colorectal Dis. 2007;22(11):1319–24. PubMed

Maris A, Devreese AM, D'Hoore A, Penninckx F, Staes F. Treatment options to improve anorectal function following rectal resection: a systematic review. Colorectal Dis. 2013;15(2):e67. PubMed

Richter HE, Matthews CA, Muir T, Takase‐Sanchez MM, Hale DS, Van Drie D, et al. A vaginal bowel‐control system for the treatment of fecal incontinence. Obstet Gynecol Surv. 2015;70(6):387–8. PubMed

Carapeti EA, Kamm MA, Phillips RK. Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg. 2000;87(1):38–42. PubMed

Bharucha AE, Fletcher JG, Camilleri M, Edge J, Carlson P, Zinsmeister AR. Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 2014;12(5):843–51. quiz e44. PubMed PMC

Bach FL, Sairally BZF, Latthe P. Effect of oestrogen therapy on faecal incontinence in postmenopausal women: a systematic review. Int Urogynecol J. 2020;31(7):1289–97. PubMed PMC

Donnelly V, O'Connell PR, O'Herlihy C. The influence of oestrogen replacement on faecal incontinence in postmenopausal women. BJOG. 1997;104(3):311–15. PubMed

Pinedo G, Garcia E, Zarate A, León F, Bellolio F, Molina M, et al. Are topical oestrogens useful in faecal incontinence? Double‐blind randomized trial. Colorectal Dis. 2009;11(4):390–3. PubMed

De Ligny WR, Kerkhof MH, Ruiz‐Zapata AM. Regenerative medicine as a therapeutic option for fecal incontinence: a systematic review of preclinical and clinical studies. Am J Obstet Gynecol. 2019;220(2):142–54. PubMed

Gras S, Tolstrup CK, Lose G. Regenerative medicine provides alternative strategies for the treatment of anal incontinence. Int Urogynecol J. 2017;28(3):341–50. PubMed

de la Portilla F, Guerrero JL, Maestre MV, Leyva L, Mera S, Garcia‐Olmo D, et al. Treatment of fecal incontinence with autologous expanded mesenchymal stem cells: results of a pilot Study. Colorectal Dis. 2020;28:28. PubMed

Sarveazad A, Newstead GL, Mirzaei R, Joghataei MT, Bakhtiari M, Babahajian A, et al. A new method for treating fecal incontinence by implanting stem cells derived from human adipose tissue: preliminary findings of a randomized double‐blind clinical trial. Stem Cell Res Ther. 2017;8(1):1–10. PubMed PMC

Boyer O, Bridoux V, Giverne C, Bisson A, Koning E, Leroi A‐M, et al. Autologous myoblasts for the treatment of fecal incontinence: results of a phase 2 randomized placebo‐controlled study (MIAS). Ann Surg. 2018;267(3):443–50. PubMed PMC

Scaglia M, Delaini G, Destefano I, Hultén L. Fecal incontinence treated with acupuncture‐a pilot study. Auton Neurosci. 2009;145(1‐2):89–92. PubMed

Franco J, Agulhon A, Viani F, Viebig R. Systemic acupuncture in patients with faecal incontinence. Compl Ther Clin Pract. 2016;24:162–6. PubMed

Ratto C, Buntzen S, Aigner F, Altomare DF, Heydari A, Donisi L, et al. Multicentre observational study of the Gatekeeper for faecal incontinence. Br J Surg. 2016;103(3):290–9. PubMed PMC

Brusciano L, Tolone S, Del Genio G, Grossi U, Schiattarella A, Piccolo FP, et al. Medium‐term outcomes of gatekeeper implantation for fecal incontinence. Tech Coloproctol. 2020;24(4):367. PubMed

Kuiper SZ, Dirksen CD, Breukink SO. Proctological oblivion. Colorectal Dis: Off J Association Coloproctol Great Br Irel. 2021;23(3):573. PubMed

Assmann S, Keszthelyi D, Kleijnen J, Kimman M, Anastasiou F, Bradshaw E, et al. The development of a faecal incontinence core outcome set: an international Delphi study protocol. Int J Colorectal Dis. 2021;36(3):617–22. PubMed PMC